Thermo Fisher Scientific | TMO - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Abbott USD 10.46B 1.15B 2026-06
Agilent USD 1.44B 9M 2026-03
Becton, Dickinson and Co. USD 24.13B 19.54B 2026-03
Bio Techne USD 235.92M 5.5M 2026-03
Bio-Rad Laboratories USD 6.85B 6.21B 2026-03
Boston Scientific USD 4.15B 107M 2026-03
Bruker USD 813.2M 87.7M 2026-03
Charles River Laboratories USD 875.93M 42.48M 2026-03
Danaher USD 52.58B 368M 2026-06
Dentsply International USD 1.32B 895M 2026-03
Edwards Lifesciences USD 1.13B 65.4M 2026-03
General Electric Aerospace USD 17.64B 417M 2026-06
Henry Schein USD 3.17B 77M 2026-03
Illumina USD 852M 51M 2026-03
Intuitive Surgical USD 1.91B 3.6M 2026-06
IQVIA Holdings USD 6.22B 4.53B 2026-03
Laboratory Of America USD 3.13B 6.3M 2026-03
Medtronic USD 7.72B 436M 2026-03
Mettler Toledo International USD 713.2M 64.61M 2026-03
Myriad Genetics USD 212.8M 16.2M 2025-12
Olympus JPY 268.42B 35.37B 2026-03
OraSure Technologies USD 40.35M 2.45M 2025-12
Quest Diagnostics USD 2.5B 76M 2026-03
Repligen USD 174.27M 3.67M 2026-03
Revvity USD 628.34M 2.12M 2026-03
Stryker USD 4.92B 284M 2026-03
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Veracyte USD 119.99M 3.99M 2026-03
Waters USD 1.12B 457.15M 2026-03
Zimmer Biomet Holdings USD 1.69B 249.3M 2026-03